Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced the initiation of the SIMPACT Sacroiliac Joint (SI) Fixation Outcomes Study, with Dr. Keith Maxwell of Southeastern Sports Medicine and Orthopedics in Asheville, North Carolina.

MDPR1

Image: Life Spine launches SIMPACT Sacroiliac Joint Fixation outcomes study. Photo: Courtesy of Life Spine, Inc.

SIMPACT is a cannulated and fenestrated screw, intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis through a lateral approach. SIMPACT also incorporates the proprietary surface technology OSSEO-LOC™, and is available in multiple lengths to accommodate varying patient anatomy.

Mariusz Knap, Vice President of Marketing and Business Development for Life Spine said: “SIMPACT joins our recently released PROLIFT® Expandable Outcomes Study, further demonstrating our commitment to providing robust investment into clinical studies which evaluate the safety and efficacy of our products. As well as adding to the body of data validating our state-of-the-art product offering, these studies will demonstrate possible medical economic savings and highlight other advantages associated with new technologies such as SIMPACT.”

Dr. Keith Maxwell who is the principal investigator for the study notes, “With more than 22% of lower back pain originating from the sacroiliac joint1, the market for SI joint fixation continues to grow as better diagnostic tools and better understanding of the pathology evolve. SIMPACT has streamlined the SI joint fixation procedure for me and my patients by creating a screw design that is self-drilling, resulting in fewer surgical steps. I continue to see excellent results in treating sacroiliac joint disruptions and degenerative sacroiliitis, and we expect these results to continue throughout the course of this study.”

Source: Company Press Release